Kingfisher PLC has announced the purchase of 25,000 ordinary shares on 26 February 2026 for cancellation as part of its £300 million share repurchase programme. The volume-weighted average price paid per share was £3.6796, with the highest price at £3.6920 and the lowest at £3.6690. This transaction, conducted with Goldman Sachs International on the London Stock Exchange, brings the total shares purchased under the programme's fifth tranche to 19,063,200.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 26 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
26 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.6796
Highest price paid per share:
£3.6920
Lowest price paid per share:
£3.6690
To date, Kingfisher has purchased 19,063,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.6796
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 26 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.6720
09:31:41
XLON
1,084
1397230783184060
3.6710
09:31:41
XLON
958
1397230783184062
3.6690
09:44:58
XLON
1,090
1397230783185194
3.6780
10:14:25
XLON
923
1397230783187668
3.6750
10:28:42
XLON
911
1397230783189012
3.6740
10:59:35
XLON
935
1397230783191295
3.6700
11:24:21
XLON
989
1397230783193248
3.6790
11:55:31
XLON
735
1397230783195198
3.6880
12:20:29
XLON
986
1397230783197101
3.6800
12:53:34
XLON
1,066
1397230783199909
3.6830
13:21:19
XLON
505
1397230783202006
3.6830
13:21:19
XLON
476
1397230783202007
3.6840
13:45:17
XLON
980
1397230783204554
3.6850
14:09:27
XLON
706
1397230783207159
3.6850
14:09:27
XLON
421
1397230783207160
3.6870
14:26:49
XLON
955
1397230783208916
3.6920
14:35:13
XLON
1,056
1397230783212205
3.6860
14:45:00
XLON
1,087
1397230783215259
3.6720
14:57:07
XLON
971
1397230783218288
3.6700
15:06:28
XLON
199
1397230783221432
3.6700
15:06:28
XLON
818
1397230783221433
3.6740
15:16:57
XLON
1,055
1397230783223849
3.6770
15:29:21
XLON
1,034
1397230783226629
3.6810
15:43:45
XLON
910
1397230783230355
3.6780
16:01:09
XLON
1,013
1397230783233848
3.6830
16:13:00
XLON
926
1397230783236774
3.6870
16:17:50
XLON
1,032
1397230783238275
3.6910
16:24:03
XLON
943
1397230783240107
3.6910
16:25:15
XLON
236
1397230783240487
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
